Common Measures for National Institute of Mental Health Funded Research

Biological Psychiatry

Volumn 79, Issue 12, 2016, Pages e91-e96

  Barch, Deanna M ^a   Gotlib, Ian H ^b   Bilder, Robert M ^c   Pine, Daniel S ^d   Smoller, Jordan W ^e   Brown, C Hendricks ^f   Huggins, Wayne ^g   Hamilton, Carol ^g   Haim, Adam ^h   Farber, Gregory K ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g RTI INTERNATIONAL   (United States)

^h Office of Clinical Research and Office of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; DATA PROCESSING; DEMOGRAPHY; FUNDING; GENETIC ASSOCIATION; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; NATIONAL HEALTH ORGANIZATION; NOTE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL STATUS; SUBSTANCE ABUSE; FINANCIAL MANAGEMENT; METHODOLOGY; STANDARDS; UNITED STATES;

HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84958259169     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.07.006     Document Type: Note

References (41)

1. 1 Hamilton, C.M., Strader, L.C., Pratt, J.G., Maiese, D., Hendershot, T., Kwok, R.K., et al. The PhenX Toolkit: Get the most from your measures. Am J Epidemiol 174 (2011), 253–260.
2. 2 McCarty, C.A., Huggins, W., Aiello, A.E., Bilder, R.M., Hariri, A., Jernigan, T.L., et al. PhenX RISING: Real world implementation and sharing of PhenX measures. BMC Med Genomics, 7, 2014, 16.
3. 3 Pan, H., Tryka, K.A., Vreeman, D.J., Huggins, W., Phillips, M.J., Mehta, J.P., et al. Using PhenX measures to identify opportunities for cross-study analysis. Hum Mutat 33 (2012), 849–857.
4. 4 Stover, P.J., Harlan, W.R., Hammond, J.A., Hendershot, T., Hamilton, C.M., PhenX: A toolkit for interdisciplinary genetics research. Curr Opin Lipidol 21 (2010), 136–140.
5. 5 Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap cooperative group during its first two years. Med Care 45 (2007), S3–S11.
6. 6 Gershon, R.C., Cella, D., Fox, N.A., Havlik, R.J., Hendrie, H.C., Wagster, M.V., Assessment of neurological and behavioural function: The NIH Toolbox. Lancet Neurol 9 (2010), 138–139.
7. 7 Perez, L., Huang, J., Jansky, L., Nowinski, C., Victorson, D., Peterman, A., Cella, D., Using focus groups to inform the Neuro-QOL measurement tool: Exploring patient-centered, health-related quality of life concepts across neurological conditions. J Neurosci Nurs 39 (2007), 342–353.
8. 8 Saver, J.L., Warach, S., Janis, S., Odenkirchen, J., Becker, K., Benavente, O., et al. Standardizing the structure of stroke clinical and epidemiologic research data: The National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke 43 (2012), 967–973.
9. 9 Loring, D.W., Lowenstein, D.H., Barbaro, N.M., Fureman, B.E., Odenkirchen, J., Jacobs, M.P., et al. Common data elements in epilepsy research: Development and implementation of the NINDS epilepsy CDE project. Epilepsia 52 (2011), 1186–1191.
10. 10 Maiese, D.R., Hendershot, T., Strader, L.C., Wagener, D., Hammond, J.A., Huggins, W., et al. PhenX: Establishing a Consensus Process to Select Common Measures for Collaborative Research. 2013, RTI Press, Research Triangle Park, NC RTI Press Publication NO MR-0027-1310.
11. 11 Conway, K.P., Vullo, G.C., Kennedy, A.P., Finger, M.S., Agrawal, A., Bjork, J.M., et al. Data compatibility in the addiction sciences: An examination of measure commonality. Drug Alcohol Depend 141 (2014), 153–158.
12. 12 Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B., McGlashan, T.H., Perkins, D.O., et al. North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33 (2007), 665–672.
13. 13 Addington, J., Cornblatt, B.A., Cadenhead, K.S., Cannon, T.D., McGlashan, T.H., Perkins, D.O., et al. At clinical high risk for psychosis: Outcome for nonconverters. Am J Psychiatry 168 (2011), 800–805.
14. 14 Cadenhead, K.S., Addington, J., Cannon, T., Cornblatt, B., McGlashan, T., Perkins, D., et al. Treatment history in the psychosis prodrome: Characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry 4 (2010), 220–226.
15. 15 Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., et al. Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Arch Gen Psychiatry 65 (2008), 28–37.
16. 16 Seidman, L.J., Giuliano, A.J., Meyer, E.C., Addington, J., Cadenhead, K.S., Cannon, T.D., et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: Relationship to family history and conversion to psychosis. Arch Gen Psychiatry 67 (2010), 578–588.
17. 17 Velthorst, E., Nieman, D.H., Becker, H.E., van de Fliert, R., Dingemans, P.M., Klaassen, R., et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 109 (2009), 60–65.
18. 18 Woods, S.W., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R., et al. Validity of the prodromal risk syndrome for first psychosis: Findings from the North American Prodrome Longitudinal Study. Schizophr Bull 35 (2009), 894–908.
19. 19 Hall, D., Huerta, M.F., McAuliffe, M.J., Farber, G.K., Sharing heterogeneous data: The national database for autism research. Neuroinformatics 10 (2012), 331–339.
20. 20 Luby, J., Belden, A., Botteron, K., Marrus, N., Harms, M.P., Babb, C., et al. The effects of poverty on childhood brain development: The mediating effect of caregiving and stressful life events. JAMA Pediatr 167 (2013), 1135–1142.
21. 21 Luby, J.L., Barch, D.M., Belden, A., Gaffrey, M.S., Tillman, R., Babb, C., et al. Maternal support in early childhood predicts larger hippocampal volumes at school age. Proc Natl Acad Sci U S A 109 (2012), 2854–2859.
22. 22 Butterworth, P., Cherbuin, N., Sachdev, P., Anstey, K.J., The association between financial hardship and amygdala and hippocampal volumes: Results from the PATH through life project. Soc Cogn Affect Neurosci 7 (2012), 548–556.
23. 23 Hanson, J.L., Chandra, A., Wolfe, B.L., Pollak, S.D., Association between income and the hippocampus. PLoS One, 6, 2011, e18712.
24. 24 Bourdon, K.H., Goodman, R., Rae, D.S., Simpson, G., Koretz, D.S., The Strengths and Difficulties Questionnaire: U.S. normative data and psychometric properties. J Am Acad Child Adolesc Psychiatry 44 (2005), 557–564.
25. 25 Goodman, R., Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry 40 (2001), 1337–1345.
26. 26 Goodman, R., Meltzer, H., Bailey, V., The Strengths and Difficulties Questionnaire: A pilot study on the validity of the self-report version. Eur Child Adolesc Psychiatry 7 (1998), 125–130.
27. 27 Kovacs, S., Sharp, C., Criterion validity of the Strengths and Difficulties Questionnaire (SDQ) with inpatient adolescents. Psychiatry Res 219 (2014), 651–657.
28. 28 Muris, P., Meesters, C., Eijkelenboom, A., Vincken, M., The self-report version of the Strengths and Difficulties Questionnaire: Its psychometric properties in 8- to 13-year-old non-clinical children. Br J Clin Psychol 43 (2004), 437–448.
29. 29 Muris, P., Meesters, C., van den Berg, F., The Strengths and Difficulties Questionnaire (SDQ)—further evidence for its reliability and validity in a community sample of Dutch children and adolescents. Eur Child Adolesc Psychiatry 12 (2003), 1–8.
30. 30 Bird, H.R., Canino, G.J., Davies, M., Ramirez, R., Chavez, L., Duarte, C., Shen, S., The Brief Impairment Scale (BIS): A multidimensional scale of functional impairment for children and adolescents. J Am Acad Child Adolesc Psychiatry 44 (2005), 699–707.
31. 31 Gold, L.H., DSM-5 and the assessment of functioning: The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). J Am Acad Psychiatry Law 42 (2014), 173–181.
32. 32 Konecky, B., Meyer, E.C., Marx, B.P., Kimbrel, N.A., Morissette, S.B., Using the WHODAS 2.0 to assess functional disability associated with DSM-5 mental disorders. Am J Psychiatry 171 (2014), 818–820.
33. 33 Ustun, T.B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ 88 (2010), 815–823.
34. 34 Grant, K.E., Compas, B.E., Thurm, A.E., McMahon, S.D., Gipson, P.Y., Stressors and child and adolescent psychopathology: Measurement issues and prospective effects. J Clin Child Adolesc Psychol 33 (2004), 412–425.
35. 35 Tiet, Q.Q., Bird, H.R., Hoven, C.W., Moore, R., Wu, P., Wicks, J., et al. Relationship between specific adverse life events and psychiatric disorders. J Abnorm Child Psychol 29 (2001), 153–164.
36. 36 Kubany, E.S., Haynes, S.N., Leisen, M.B., Owens, J.A., Kaplan, A.S., Watson, S.B., Burns, K., Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: The Traumatic Life Events Questionnaire. Psychol Assess 12 (2000), 210–224.
37. 37 Peirce, J.M., Burke, C.K., Stoller, K.B., Neufeld, K.J., Brooner, R.K., Assessing traumatic event exposure: Comparing the Traumatic Life Events Questionnaire to the Structured Clinical Interview for DSM-IV. Psychol Assess 21 (2009), 210–218.
38. 38 Cohen, S., Janicki-Deverts, D., Who's stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006 and 2009. J Appl Soc Psychol 42 (2012), 1320–1334.
39. 39 Cohen, S., Constrasting the hassle scale and the perceived stress scale. Am Psychol 41 (1986), 716–719.
40. 40 Gold, J.M., Hahn, B., Zhang, W.W., Robinson, B.M., Kappenman, E.S., Beck, V.M., Luck, S.J., Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry 67 (2010), 570–577.
41. 41 Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.